Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

about

An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.

P2860

Q39048531-16BB672D-1EFE-4F39-81C4-6FE1B0E7F2BE

P2860

Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

Item

http://www.wikidata.org/entity/Q40650174

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Experience with anidulafungin ...... and graft-versus-host disease.

@en

type

Item

label

Experience with anidulafungin ...... and graft-versus-host disease.

@en

prefLabel

Experience with anidulafungin ...... and graft-versus-host disease.

@en

P1476

Experience with anidulafungin ...... and graft-versus-host disease.

@en

P2093

A Bermúdez

http://www.w3.org/2001/XMLSchema#string

A Insunza

http://www.w3.org/2001/XMLSchema#string

C Richard

http://www.w3.org/2001/XMLSchema#string

C de Miguel

http://www.w3.org/2001/XMLSchema#string

E Conde

http://www.w3.org/2001/XMLSchema#string

L Yáñez

http://www.w3.org/2001/XMLSchema#string

M Colorado

http://www.w3.org/2001/XMLSchema#string

M López-Duarte

http://www.w3.org/2001/XMLSchema#string

P Ibarrondo

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of echinocandin antifungals

Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation

Reduced mortality after allogeneic hematopoietic-cell transplantation.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.

Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.

Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint.

P304

761-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TID.12429

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26250790

http://www.w3.org/2001/XMLSchema#string

Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

about

P2860

P2860

Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698